CancerX Startup Accelerator

What CancerX Startup Accelerator does

CancerX is a public-private partnership accelerator and community platform launched in 2023 to accelerate digital innovation in oncology. Founded in coordination with HHS's Office of the Assistant Secretary for Technology Policy as part of the InnovationX program, it is hosted by two founding anchor members, Moffitt Cancer Center and Advocate Health, and operates from Tampa, Florida. The organization runs an annual four-month accelerator cohort (February through July) that selects 12-16 early-stage digital health startups per year through a competitive process, matching each with at least two Champion organizations (health systems, pharmaceutical companies, or investors) who provide mentorship, pilot opportunities, and pathways to commercial agreements. CancerX complements the accelerator with the Constellation online community platform, a Data Sprint initiative partnering with CMMI, NCI, FDA, and ONC to advance oncology data standards, and a Financial Toxicity initiative providing digital tools such as a Digital Navigation ROI Calculator and a Digitally Enabled Patient Navigation Blueprint for health systems. The 2024 inaugural cohort's 16 startups collectively raised over $42 million in venture funding, signed 9 health system contracts, and employed 234 individuals; the 2025 cohort reported 100% of startups advancing at least one strategic opportunity. Membership is offered through tiered annual subscriptions (Foundational, Premier Contributor, Thought Leader, Innovation Leader, Innovation Catalyst), and federal partnership support is provided via HHS. As a consortium-style nonprofit entity with a core team of approximately 12-15 staff, CancerX is structurally a convening and ecosystem-orchestration organization rather than a product or technology vendor.

Name

CancerX Startup Accelerator

Legal name

CancerX

Website

https://cancerx.health

Company type

Private

Founded year

2023

Operating status

Operating

Short description

CancerX is a public-private partnership accelerator, launched in 2023 under HHS InnovationX and hosted by Moffitt Cancer Center and Advocate Health, that runs an annual cohort-based program and community platform to connect early-stage digital health startups with healthcare, pharma, and investor champions for cancer care innovation.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Accelerator

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLACAGAH

Oncology Pathways & Precision Medicine Decision Support

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

SECONDARYHLALAGAH

Oncology Telemedicine Platforms

Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

SECONDARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Oncology innovation accelerator
• Digital health startups
• Cancer care solutions
• Startup mentorship programs
• Public-private partnerships

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Membership Fees: CancerX operates with membership tiers (Foundational Member, Premier Contributor, Thought Leader, Innovation Leader, Innovation Catalyst) that provide varying levels of access to events, insights reports, community forums, marketplace listings, and accelerator benefits. The organization is a public-private partnership hosted by Advocate Health and Moffitt Cancer Center.
2. Federal Government Partnership: Launched in coordination with the Office of the Assistant Secretary for Technology Policy (ASTP) as part of the HHS InnovationX program. This public-private partnership model likely includes government funding and support.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

CancerX operates an annual Accelerator program that matches early-stage digital health startups with champion organizations (health systems, life sciences firms, payors, and investors) for mentorship, education, funding access, and pilot opportunities. It complements this with the Constellation online community platform and specialized initiatives such as the Data Sprint (real-world oncology datasets) and the Financial Toxicity Initiative (digital tools for patient financial navigation in cancer care).

Product overview

CancerX is a public-private partnership that accelerates digital innovation in oncology through three interconnected pillars: an annual Accelerator program that provides mentorship, education, and funding access to early-stage startups; the Constellation virtual community platform for networking and collaboration; and Special Initiatives including Data Sprint and Financial Toxicity programs. The Accelerator Program is the core offering—a 4-month cohort-based program matching startups with champion organizations for mentorship and pilot opportunities. The Constellation serves as the community engagement platform providing members-only access to forums, events, and resources. Data Sprint and Financial Toxicity are specialized initiatives addressing data standards and patient financial burden respectively.

Differentiator

Problem solved

Functional benefit

Products and services

• CancerX Accelerator Program A flagship 4-month accelerator program that matches early-stage digital health startups with Champion organizations from health systems, life sciences, payors, and investors. Provides mentorship, education, funding access, and clinical partnership opportunities to startups developing solutions for cancer prevention, diagnosis, treatment, care coordination, and survivorship.
• CancerX Constellation A virtual online community providing oncology experts and healthcare leaders a private environment to network, collaborate, engage in discussion, and participate in CancerX Initiatives. Includes announcements, early access to reports, exclusive events, forum boards, marketplace listings, and thought leadership content.
• CancerX Data Sprint An initiative to build comprehensive real-world datasets in oncology through collaboration with federal government and industry. Works with CMMI, NCI, FDA, and ONC to advance cancer-related data standards and support implementation of USCDI+ Oncology data elements.
• Financial Toxicity Initiative A set of digital innovation resources including a Solutions Catalog, Core Competencies, Financial Navigation Guide, Digital Navigation ROI Calculator, and Digitally Enabled Patient Navigation Blueprint to help health systems address financial barriers in cancer care and reduce patient costs.
• CancerXpress A weekly educational curriculum offered within the Accelerator program, covering four tracks: working with health systems, working with industry, working with the public sector, and a speaker series on scaling business within oncology.

Quantifiable outcome

• 2024 inaugural cohort: 16 startups raised over $42M in venture funding, signed 9 contracts with health systems, 2+ investments secured, 234 individuals employed
• +3 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

18 partnerships are on record, tiered core, major, flagship and minor.

• ClearwatercoreTechnology or Integration · 24 February 2026Strategic partnership to launch CancerX Cybersecurity Mark, Powered by Clearwater. Program prepares emerging oncology technologies to meet enterprise-grade security standards before deployment in health systems. Two-phase program: assessment (readiness evaluation, gap analysis, prioritized roadmap) and preparation (fractional vCISO support, managed security services, continuous monitoring).
• MedHaulmajorStrategic or Co-development Partner · 19 February 2026Partnership to release national report on transportation barriers in cancer care. MedHaul is a digital health and mobility platform coordinating medically appropriate transport for patients. Joint roundtable brought together cancer center executives, clinical trial operators, pharma partners and digital health innovators to address transportation challenges.
• Rush University System for HealthmajorStrategic or Co-development Partner · 12 January 2026New Champion organization joining CancerX network for 2026 cohort. Provides mentorship, validation, and real-world insight to help accelerate startup learning, deployment and scale in clinical settings.
• Atlantic Health SystemmajorStrategic or Co-development Partner · 12 January 2026New Champion organization joining CancerX network for 2026 cohort. Contributes to champion-startup matching process to help startups validate ideas and bring them to life in real-world care settings.
• AstraZenecamajorStrategic or Co-development Partner · 12 January 2026New Champion organization joining CancerX network. VP Medical Excellence, Strategy & Operations (Shirin Ahmed) highlighted that championing CancerX aligns with their commitment to advancing oncology innovation through partnership, bringing together startups, health systems, and industry.
• NovartismajorStrategic or Co-development Partner · 12 January 2026New Champion organization joining CancerX network for 2026 cohort. Industry partner that brings pharmaceutical expertise and potential investment opportunities to the accelerator ecosystem.
• KidsXcoreStrategic or Co-development Partner · 21 October 2024Nationally recognized community of pediatric hospitals with 30+ member hospitals. Partnership creates unique opportunities for startups in pediatric oncology with 2 of 15 available spots in 2025 cohort reserved for pediatric oncology companies. KidsX provides additional tailored mentorship and programming.
• Advocate HealthflagshipStrategic or Co-development PartnerOne of two founding anchor members of CancerX consortium. One of the nation's largest nonprofit health systems (third-largest in US) with 130 cancer locations including an NCI-designated Comprehensive Cancer Center. Serves as national steering partner and accelerator Champion, providing mentorship, pilot opportunities, and innovation ecosystem access.
• Moffitt Cancer CenterflagshipStrategic or Co-development PartnerHost organization and founding home of CancerX. Only NCI-designated Comprehensive Cancer Center in Florida. Provides executive leadership (Xavier Avat as Executive Sponsor, Dr. Kamal Jethwani as CancerX Lead), operational support, and hosts annual Innovation Summit. Driving force behind CancerX mission since its inception two years ago.
• Office of the Assistant Secretary for Technology Policy (ASTP)coreStrategic or Co-development PartnerFederal government partner within HHS. CancerX was launched in coordination with ASTP as part of the HHS InnovationX program launched in 2018. Provides government collaboration opportunities and policy alignment for CancerX initiatives.
• Office of the National Coordinator for Health Information Technology (ONC)coreStrategic or Co-development PartnerFederal government partner collaborating on health IT standards. Partnered with CancerX Data Sprint initiative to support the ongoing collaboration between CMMI's Enhancing Oncology Model (EOM) and ONC's USCDI+ Oncology extension development.
• MassChallengemajorStrategic or Co-development PartnerChampion organization providing startup support and resources. Major accelerator and innovation organization that contributes to the CancerX ecosystem with mentorship and program support.
• Dana-Farber Cancer InstitutemajorStrategic or Co-development PartnerChampion organization and one of the nation's leading cancer research and treatment centers. Provides clinical expertise, mentorship, and potential pilot opportunities for accelerator startups.
• Memorial Sloan Kettering Cancer CentermajorStrategic or Co-development PartnerChampion organization and one of the world's oldest private cancer centers. Digital Venture Lead Rick Peng highlighted CancerX's unique effectiveness in bringing together different stakeholders from across the healthcare ecosystem to coordinate innovation.
• MercuryminorStrategic or Co-development PartnerChampion organization contributing to the 2025 accelerator program. Provides industry expertise and mentorship support for selected startups.
• Elevance HealthminorStrategic or Co-development PartnerHealth insurance payor and Champion organization. Spencer Ward, Portfolio Director, represents Elevance Health on CancerX Steering Committee, bringing payer perspective to accelerator programming.
• Johnson & JohnsonmajorStrategic or Co-development PartnerPharmaceutical company and Champion organization. Dr. Ashita S. Batavia, Head of Hematology & Oncology Data Sciences, serves on CancerX Steering Committee, providing industry leadership for the accelerator.
• InnsenaminorStrategic or Co-development PartnerDigital health focused organization and Champion organization contributing to the 2025 accelerator program with industry expertise and mentorship.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• MassChallenge HealthTech: Large global accelerator network with a dedicated HealthTech track. CancerX already lists MassChallenge as a Champion and the two compete for the same digital health startup pipeline and enterprise sponsors.
• StartX Med: Stanford-affiliated accelerator with a dedicated Med track. Comparable in mission (university/health system-anchored digital health accelerator) and competes for top oncology and digital health founders.
• Matter Health (Chicago): Chicago-based healthcare innovation hub and accelerator. Comparable accelerator model targeting the same cohort of digital health founders and enterprise healthcare sponsors in the Midwest — and CancerX already runs events in Chicago.
• Rock Health: Venture fund and digital health incubator supporting early-stage companies. Directly competes for digital health startup deal flow, particularly with enterprise partners in pharma and providers.
• KidsX: Pediatric digital health accelerator consortium of 30+ children's hospitals. Already a CancerX partner (reserving slots for pediatric oncology in 2025 cohort) and a directly comparable hospital-led accelerator model in an adjacent sub-vertical.
• Blueprint Health: Healthcare-focused accelerator supporting early-stage digital health companies. Direct comparator in cohort model, mentor network composition, and enterprise sponsor relationships.

Emerging players

• Jumpstart Health Investors: Healthcare-focused venture firm and accelerator. Targets the same early-stage digital health startup pool and competes for health system and corporate venture sponsorship.

Broad incumbents

• HHS InnovationX: Broader HHS innovation accelerator initiative under which CancerX sits. Provides shared infrastructure, policy alignment, and federal relationships but operates at a much larger scale across multiple disease areas.
• ARPA-H: Federal Advanced Research Projects Agency for Health, focused on cancer and other high-impact biomedical challenges. Functions as a much larger, federally funded peer in oncology innovation funding and program design that overlaps with CancerX's HHS InnovationX positioning.
• Mayo Clinic Platform / Mayo Innovation Exchange: Major US health system accelerator and innovation platform. Operates a similar accelerator-style model for digital health startups, providing validation, pilots, and clinical access — directly comparable Champion-style value proposition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments40 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CancerX Startup Accelerator